Table 2 Association between retinol intake and CRC risk.
Retinol intake (µg/day) | Controls | Cases | Model 1 [OR (95% CI)] | Model 2 [OR (95% CI)] |
|---|---|---|---|---|
Total (n = 2769) | ||||
T1 (< 48.75) | 616 (33.4) | 443 (48.0) | 1.00 | 1.00 |
T2 (48.75–88.17) | 615 (33.3) | 306 (33.2) | 0.69 (0.58–0.83) | 0.68 (0.54–0.86) |
T3 (> 88.17) | 615 (33.3) | 174 (18.9) | 0.39 (0.32–0.48) | 0.49 (0.37–0.63) |
p for trend | < 0.001 | < 0.001 | ||
Men (n = 1875) | ||||
T1 (< 47.20) | 417 (33.4) | 317 (50.7) | 1.00 | 1.00 |
T2 (47.20–83.41) | 416 (33.3) | 191 (30.6) | 0.60 (0.48–0.76) | 0.58 (0.43–0.77) |
T3 (> 83.41) | 417 (33.4) | 117 (18.7) | 0.37 (0.29–0.48) | 0.43 (0.31–0.60) |
p for trend | < 0.001 | < 0.001 | ||
Women (n = 894) | ||||
T1 (< 51.54) | 198 (33.2) | 124 (41.6) | 1.00 | 1.00 |
T2 (51.54–98.79) | 199 (33.4) | 116 (38.9) | 0.93 (0.68–1.28) | 1.14 (0.75–1.72) |
T3 (> 98.79) | 199 (33.4) | 58 (19.5) | 0.47 (0.32–0.67) | 0.73 (0.46–1.15) |
p for trend | < 0.001 | < 0.001 | ||
